Related Experiment Video
Updated: Apr 29, 2026

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
Published on: January 8, 2015
When amyloids become prions
1Conformational Diseases Group; Department of Physical Chemistry; Faculty of Pharmacy; University of Barcelona (UB); Barcelona, Spain; Institut of Nanoscience and Nanotechnology of the University of Barcelona (IN2UB); Barcelona, Spain.
Abstract:
The conformational diseases, linked to protein aggregation into amyloid conformations, range from non-infectious neurodegenerative disorders, such as Alzheimer disease (AD), to highly infectious ones, such as human transmissible spongiform encephalopathies (TSEs). They are commonly known as prion diseases. However, since all amyloids could be considered prions (from those involved in cell-to-cell transmission to those responsible for real neuronal invasion), it is necessary to find an underlying cause of the different capacity to infect that each of the proteins prone to form amyloids has. As proposed here, both the intrinsic cytotoxicity and the number of nuclei of aggregation per cell could be key factors in this transmission capacity of each amyloid.
Insights
Protein aggregation causes conformational diseases like Alzheimer disease and prion diseases. Intrinsic cytotoxicity and aggregation nuclei per cell may explain differing infectious capacities of amyloid proteins.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Conformational diseases involve protein aggregation into amyloid structures.
- These diseases range from neurodegenerative disorders like Alzheimer disease (AD) to infectious transmissible spongiform encephalopathies (TSEs), collectively known as prion diseases.
- The varying infectious potential of different amyloid-forming proteins remains unexplained.
Purpose of the Study:
- To investigate the underlying factors determining the infectious capacity of amyloid proteins.
- To explore the roles of intrinsic cytotoxicity and intracellular aggregation nucleation in prion disease transmission.
Main Methods:
- This study proposes a theoretical framework based on existing literature and biochemical principles.
- It analyzes the relationship between protein aggregation kinetics, cellular toxicity, and disease transmissibility.
Main Results:
- Amyloid proteins share the potential to act as prions, facilitating cell-to-cell or organism-to-organism spread.
- Intrinsic cytotoxicity and the number of aggregation nuclei within a cell are proposed as key determinants of an amyloid's infectious capacity.
Conclusions:
- Understanding the factors governing amyloid infectivity is crucial for differentiating between various conformational diseases.
- Intrinsic cytotoxicity and aggregation nucleation offer a potential explanation for the spectrum of prion disease infectivity.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Subviral Agents
Alzheimer Disease ll: Pathophysiology
Protein Folding
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...

